#4162
Functioning neuroendocrine neoplasms: Symptomatic control with 177Lu-DOTATATE
Introduction:
Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE is recommended in unresectable and metastatic gastroenteropancreatic neuroendocrine neoplasms (NENs), however, recommendations for functioning NENs (F-NENs) are not well established. Besides PRRT impact in OS and PFS, real-life benefit in clinical control is also a relevant outcome, especially in F-NENs.
Conference:
Presenting Author:
Santos A
Authors:
Lopes-Pinto M,
Silva D,
Ribeiro S,
Oliveira J,
Ferreira G,
Keywords:
neuroendocrine neoplasm,
functioning neuroendocrine neoplasm,
carcinoid syndrome,
PRRT,
#2096
The Number of Positive Nodes Accurately Predicts Recurrence after Pancreaticoduodenectomy for Nonfunctioning Neuroendocrine Neoplasms
Introduction:
The presence of lymph node metastases is one of the most powerful predictor of recurrence after surgery for pancreatic neuroendocrine neoplasms (PanNENs), but the most appropriate nodal staging for PanNENs is unclear.
Conference:
15th Annual ENETSConcerence (2018)
Presenting Author:
Authors:
Andreasi V,
Partelli S,
Javed A,
He J,
Muffatti F,
Keywords:
pancreatic neuroendocrine neoplasms,
lymph node metastases,
surgery,
pancreaticoduodenectomy,
nodal staging,
disease-free survival,
prognosis,